DECEMBER 6–10, 2022
Henry B. Gonzalez Convention Center
San Antonio, TX
C. Kent Osborne, MD, opened a session named in his honor on Wednesday as experts discussed the interplay between estrogen receptors and HER2 signaling pathways.
Jeffrey Rosen, PhD, a pioneer of mouse modeling and mouse mammary tumorigenesis, received the William L. McGuire Memorial Lecture Award.
Ruth O’Regan, MD, and Debra Patt, MD, PhD, MBA, will take sides on the impacts of CDK4/6 inhibitors during a Thursday morning debate session.
Nicholas Turner, MD, PhD, will moderate a Thursday afternoon session that will provide an update on the current uses of liquid biopsies in metastatic disease as well as growing applications for ctDNA in clinical trials.
Madeleine M.A. Tilanus-Linthorst, MD, PhD, and Joanne Kotsopoulos, MSc, PhD, preview their Thursday afternoon presentations.
Minetta C. Liu, MD, previews a Thursday afternoon presentation on using ctDNA in detecting disease.
Komal Jhaveri, MD, FACP, will moderate discussions about current controversies in translational medicine for breast cancer.
Seema A. Khan, MD, will lead a session on Thursday afternoon looking at evolving evidence on managing patients at moderate genetic breast cancer risk.
An educational session on Thursday, moderated by Bora Lim, MD, will explore the diagnosis and treatment of less common, more challenging, breast cancers.
Ariella Hanker, PhD, and Sarat Chandarlapaty, MD, PhD, preview their presentations on inhibitors, set for Thursday afternoon.
Subscribe to get regular news updates from SABCS.org and SABCS Meeting News.